However, other studies have also shown that STAT2 could promote the tumorigenesis of colorectal cancer (CRC) by upregulating the expression of IL-6 and activating the STAT3 signaling pathway (Gamero et al., 2010). This evidence concerns the gene STAT3 and colorectal carcinoma.